InvestorsHub Logo
Followers 72
Posts 6896
Boards Moderated 0
Alias Born 12/07/2011

Re: scottsmith post# 222450

Monday, 03/26/2018 2:27:32 PM

Monday, March 26, 2018 2:27:32 PM

Post# of 403092
I see 7-0. No debate their.
Kevetrin was a success. They clearly saw the primary of modulation with in the tumor. There is proof on their website. They just needed to see it happen not once but twice. Cut the trial to save expenses and move to Oral and BOOM! If they can move to Oral it will be the most sought after drug n the history of cancer research. IMO.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News